Monthly Newsletter

 

VIEW THE LATEST ISSUE

SUBSCRIBE Here

Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies

publication date: Sep 10, 2025
 | 
author/source: Thermo Fisher Scientific

 

 

thermo-fisher-scientific-secures-rampd-100-awards

 

Achievements highlight cutting-edge technology in omics research, bioproduction and DNA purification

Thermo Fisher Scientific Inc., the world leader in serving science, is proud to receive three R&D 100 Awards for innovations designed to advance scientific discovery in critical areas like precision medicine and cell and gene therapy research and development. All three awarded products were recognized in the Analytical/Test category, which highlights breakthroughs in instrumentation, imaging, testing systems, laboratory equipment and life sciences technologies, demonstrating Thermo Fisher’s commitment to advancing groundbreaking research.

The Thermo Scientific™ Stellar™ Mass Spectrometer* (MS) sets a new benchmark for precision in biomarker research. With 10 times greater sensitivity when analyzing five times more compounds than traditional systems, it empowers researchers to quickly confirm and verify candidate drugs and biomarker molecules including peptides, metabolites and lipids. This breakthrough accelerates insights in fields such as translational omics, toxicology and bioanalysis—helping drive the development of advanced therapies for complex diseases and supporting progress in precision medicine and biopharmaceutical innovation.

The Thermo Scientific™ KingFisher™ PlasmidPro Maxi Processor* (PlasmidPro) is the only fully automated system for maxi-scale plasmid DNA (pDNA) purification, delivering high-purity pDNA in just 75 minutes—half the time of conventional methods. Its all-in-one cartridge design eliminates extra equipment, reduces contamination risk and streamlines workflows. With the rapidly growing demand for pDNA, PlasmidPro provides a fully automated “press and go” solution that helps accelerate the discovery and development of emerging therapies.

The SteriSEQ™ Rapid Sterility Testing Kit* aims to accelerate cell therapy delivery while enhancing safety. SteriSEQ uses real-time PCR (qPCR) technology to detect bacterial and fungal DNA in test samples and tests for fungi and bacteria simultaneously with minimal volume, supporting optimized sample use. It provides reliable results in less than a day, enabling cell therapy manufacturers to ensure product safety through early contamination detection, and its simple qPCR workflow helps minimize training requirements and simplify support and maintenance. SteriSEQ offers a fast, effective solution for cell therapy manufacturers, advancing the delivery of cell therapy innovations to patients. 

“Our Mission drives our innovation, ensuring we’re delivering solutions that help push our customers’ discovery forward and expand the boundaries of science,” said Karen Nelson, chief scientific officer, Thermo Fisher Scientific. “We are honored to be recognized for our commitment to helping drive scientific progress through advanced technology. From realizing the potential of precision medicine to automating time-consuming workflows and ensuring the safety of treatments, we’re proud to help scientists achieve deeper insights, faster timelines and safer products as we work together to bring life-changing therapies to patients.”

Established in 1963, the R&D 100 Awards is the only science and technology awards competition that recognizes new commercial products, technologies and materials that are available for sale or license for their technological significance. Sponsored by R&D World Magazine, the R&D 100 Awards recognizes and celebrates the 100 most innovative technologies of the previous year. Now in its 63rd year, the 2025 judging panel featured 54 respected industry professionals from across the globe.

 

*For Research Use Only. Not for use in diagnostic procedures.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

 

Recent news from Thermo Fisher Scientific

 


If you have not logged into the website then please enter your details below.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events